Home > Spring 2004

1. 

Jeffrey D. Sachs, Ph.D.

2. 

Richard Garfield, Dr.P.H.

Ronald Waldman, M.D., M.P.H.

3. 

Dickson Despommier, Ph.D.

4. 

Sarah, J. Schlesinger, M.D.

Elaine J. Abrams, M.D.

5. 

Seth F. Berkley, M.D.

Eve Slater, M.D.

Roy Vagelos, M.D.

6. 

Maria Freire, Ph.D.

Waafa El-Sadr, M.D., M.P.H.

7.  

Panos Papapanou, D.D.S., Ph.D.

8. 

Allan Rosenfield, M.D.

9. 

Paul Farmer, M.D., Ph.D.

Often referred to as "the father of pharmaco-philanthropy," Roy Vagelos was senior vice president of research for Merck and served as chief executive officer from 1985 to 1994 and as chairman of the board from 1986 to 1994. Under his direction, the company expanded its philanthropic efforts and set the standard in that area for other pharmaceutical companies.

Prior to joining the U.S. Department of Health and Human Services as assistant secretary, Eve Slater was senior vice president of Merck Research Laboratories external policy and vice president of corporate public affairs, the first woman to attain this rank. Dr. Slater supervised worldwide regulatory activities for all Merck medicines and vaccines, which included responsibility for working with the Food and Drug Administration.

Seth Berkley is a medical doctor specializing in infectious-disease epidemiology and international health. Dr. Berkley is the president and founder of the International AIDS Vaccine Initiative (IAVI), a global organization working to speed the search for vaccines to prevent AIDS and see that they will be rapidly available to all who need them. IAVI's focus is the developing world, where the epidemic has taken a disproportionate toll. Prior to founding IAVI, Dr. Berkley was the associate director of the Health Sciences Division at the Rockefeller Foundation. Dr. Berkley is also an adjunct associate professor of Public Health at Columbia University and of Medicine at Brown University.

Panel Discussion. The panelists respond to audience questions.